Terminated OBSERVATIONAL NCT00512031

Characterizing PAI-1 Modulation on Monocyte Adhesion

Characterizing the Effects of PAI-1 Modulation on Human Monocyte Function - The Effect of PAI-1 Post-transcriptional Regulation on Human Monocyte Adhesion

Sponsor: Vanderbilt University

Conditions Atherosclerosis

Updated 6 times since 2017 Last updated: Jul 15, 2011 Started: Jan 31, 2007 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigator left institution

Other terminated trials from Vanderbilt University

See all terminations from Vanderbilt University

Other Atherosclerosis trials with similar outcome

Browse all Atherosclerosis trials

This observational or N/A phase trial investigates Atherosclerosis and is currently terminated or withdrawn. Vanderbilt University leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated
Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States